Irene Taw, MD, Radiation Oncology, Glendale, AZ, HonorHealth Scottsdale Osborn Medical Center

IreneKTawMDMBA, CPE

Radiation Oncology Glendale, AZ

Breast Cancer, Thoracic Cancer, Urologic Cancer

Physician

Dr. Taw is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Taw's full profile

Already have an account?

Education & Training

  • University of Tennessee
    University of TennesseeMBA, Physician Executive, 2012
  • Rush University Medical Center
    Rush University Medical CenterResidency, Radiation Oncology, 1992 - 1996
  • Chicago Medical School at Rosalind Franklin University
    Chicago Medical School at Rosalind Franklin UniversityClass of 1992
  • University of CaliforniaBS, Biochemistry, 1983 - 1987

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1998 - 2022
  • IL State Medical License
    IL State Medical License 1992 - 1999
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013-2014
  • Top Doctor Phoenix Magazine, 2009, 2011
  • Best Doctor Best Doctor Inc., 2005
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Radiation Toxicity of the Lung  
    Taw, I., Hartsell W., Rubin, D, Clinical Pulmonary Medicine, 1/1/1995
  • Intratumor Heterogeneity of DNA Ploidy and Correlations with Clinical Stage and Histologic Grade in Prostate Cancer  
    Kucuk, O., Demirer, T., Gilan-Sachs, A., Taw, I., Mangold, M., Singh, S., Westerman, M.P, Journal of Surgical Oncology, 1/1/1993

Abstracts/Posters

  • Fractionated Irradiation Studies of Interferon-B as Radiosensitizer and an Antiproliferative for A549 Non-small Cell Lung Cancer Cells
    Blazek, E.R., Taw, I., and Gupta-Burt S, Radiation Research Society, 44th Annual Meeting, 4/1/1996
  • Phase I Evaluation of Cisplatin, 5-FU Infusion and WR-2721 with Radiation Therapy in Advanced Head and Neck Cancer: Protocol WR-2721-20
    Taw, I., Griem, K., Taylor, S., Recine D., Hartsell, W., and Murthy A, Proc. Of American Society for Therapeutic Radiology and Oncology 36th Annual Meeting, 10/1/1994
  • Correlation of DNA Ploidy with Stage and Histology in Prostate Cancer Patients
    Kuck, O., Demire, Y., Gilman-Sachs, A., Taw, I., Mangold, M., Joshi, H., Singh, S., Westerman, M.P, Proc. Of American Association for Cancer Research, 1/1/1991

Hospital Affiliations